Skip to search formSkip to main contentSkip to account menu

DOV 216303

Known as: DOV 216,303 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Monoamine reuptake inhibitors increase brain-derived neurotrophic factor (BDNF) activity, and this growth factor is regarded as… 
2010
2010
Triple reuptake inhibitors (TRIs) that block the dopamine transporter (DAT), norepinephrine transporter, and serotonin… 
Review
2006
Review
2006
DOV 216,303 [(+/-)-1-(3,4-dichlorophenyl)-3-azabicyclo-[3.1.0]hexane hydrochloride] is the prototype of a class of compounds… 
Highly Cited
2004
Highly Cited
2004
This report describes the first evaluation in humans of DOV 216,303, a putative antidepressive that inhibits the reuptake of…